Display options
Cite
Barret M, Batteux F, Beuvon F, et al. N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model. Fibrogenesis Tissue Repair. 2012;5(1):8doi: 10.1186/1755-1536-5-8.
Barret, M., Batteux, F., Beuvon, F., Mangialavori, L., Chryssostalis, A., Pratico, C., Chaussade, S., & Prat, F. (2012). N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model. Fibrogenesis & tissue repair, 5(1), 8. https://doi.org/10.1186/1755-1536-5-8
Barret, Maximilien, et al. "N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model." Fibrogenesis & tissue repair vol. 5,1 (2012): 8. doi: https://doi.org/10.1186/1755-1536-5-8
Barret M, Batteux F, Beuvon F, Mangialavori L, Chryssostalis A, Pratico C, Chaussade S, Prat F. N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model. Fibrogenesis Tissue Repair. 2012 May 28;5(1):8. doi: 10.1186/1755-1536-5-8. PMID: 22640979; PMCID: PMC3482386.
Copy Download .nbib Format: NLM
Share it on

Fibrogenesis Tissue Repair. 2012 May 28;5(1):8. doi: 10.1186/1755-1536-5-8.

N-acetylcysteine for the prevention of stricture after circumferential endoscopic submucosal dissection of the esophagus: a randomized trial in a porcine model.

Fibrogenesis & tissue repair

Maximilien Barret, Frédéric Batteux, Frédéric Beuvon, Luigi Mangialavori, Ariane Chryssostalis, Carlos Pratico, Stanislas Chaussade, Frédéric Prat

Affiliations

  1. Department of Gastroenterology, Cochin Hospital, 27, rue du Faubourg St Jacques, Paris, 75014, France. [email protected].

PMID: 22640979 PMCID: PMC3482386 DOI: 10.1186/1755-1536-5-8

Abstract

BACKGROUND: Circumferential endoscopic submucosal dissection (CESD) of the esophagus would allow for both the eradication of Barrett's esophagus and its related complications, such as advanced neoplasia. However, such procedures generally induce inflammatory repair resulting in a fibrotic stricture. N-acetylcysteine (NAC) is an antioxidant that has shown some efficacy against pulmonary and hepatic fibrosis. The aim of our study was to evaluate the benefit of NAC in the prevention of esophageal cicatricial stricture after CESD in a swine model.

ANIMALS AND METHODS: Two groups of six pigs each were subjected to general anesthesia and CESD: after randomization, a first group received an oral NAC treatment regimen of 100 mg/kg/day, initiated one week before the procedure, whereas a second group was followed without any prophylactic treatment. Follow-up endoscopies took place seven, fourteen, twenty-one, and twenty-eight days after CESD. Necropsy, histological assessment of esophageal inflammation, and fibrosis were performed on day 28.

RESULTS: The median esophageal lumen diameter on day 21 (main judgment criterion) was 4 mm (range 2 to 5) in group 1 and 3 mm (range 1 to 7) in group 2 (P = 0.95). No significant difference was observed between the two groups regarding clinical evaluation (time before onset of clinically significant esophageal obstruction), number of dilations, esophageal inflammation and fibrosis, or oxidative stress damage on immunohistochemistry.

CONCLUSIONS: Despite its antioxidant effect, systemic administration of NAC did not show significant benefit on esophageal fibrosis in our animal model of esophageal wound healing within the experimental conditions of this study. Since the administered doses were relatively high, it seems unlikely that NAC might be a valuable option for the prevention of post-endoscopic esophageal stricture.

References

  1. Gastrointest Endosc. 2009 Feb;69(2):289-96 - PubMed
  2. J Mol Med (Berl). 2010 Apr;88(4):401-11 - PubMed
  3. Tissue Eng Part A. 2011 Jun;17(11-12):1643-50 - PubMed
  4. Pediatr Surg Int. 2002 Jan;18(1):24-7 - PubMed
  5. J Pediatr Surg. 2001 Oct;36(10):1504-9 - PubMed
  6. Eur Surg Res. 2001 May-Jun;33(3):225-31 - PubMed
  7. Med Hypotheses. 2009 Nov;73(5):659-61 - PubMed
  8. Endoscopy. 2007 Jan;39(1):30-5 - PubMed
  9. J Surg Res. 2005 Feb;123(2):182-7 - PubMed
  10. Gastrointest Endosc. 2003 Feb;57(2):165-9 - PubMed
  11. Gastrointest Endosc. 2011 Dec;74(6):1389-93 - PubMed
  12. N Engl J Med. 2005 Nov 24;353(21):2229-42 - PubMed
  13. Gastroenterology. 2002 Feb;122(2):458-68 - PubMed
  14. Am J Gastroenterol. 2009 Nov;104(11):2684-92 - PubMed
  15. Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1150-6 - PubMed
  16. Am J Surg. 2004 Feb;187(2):257-60 - PubMed
  17. Gastrointest Endosc. 2007 Jul;66(1):167-73 - PubMed
  18. Gastrointest Endosc. 2009 Jan;69(1):147-51 - PubMed
  19. J Immunol. 2009 May 1;182(9):5855-64 - PubMed
  20. Ann Thorac Surg. 2006 Dec;82(6):2050-8 - PubMed
  21. Gut. 2006 Dec;55(12):1704-10 - PubMed
  22. J Invest Surg. 2011;24(4):151-8 - PubMed
  23. Int Surg. 1997 Oct-Dec;82(4):371-5 - PubMed
  24. Methods Enzymol. 1994;234:482-92 - PubMed
  25. Crit Care. 2004 Apr;8(2):93-5 - PubMed
  26. Endoscopy. 2005 Nov;37(11):1111-5 - PubMed
  27. J Nutr. 2008 Oct;138(10):1872-9 - PubMed
  28. J Toxicol Clin Toxicol. 1999;37(6):759-67 - PubMed
  29. Int J Pediatr Otorhinolaryngol. 2002 May 15;63(3):179-84 - PubMed
  30. Gut. 2005 Apr;54(4):515-21 - PubMed
  31. Endoscopy. 2010 Dec;42(12):1092-5 - PubMed
  32. Gastrointest Endosc. 2007 Jan;65(1):3-10 - PubMed
  33. N Engl J Med. 2008 Jul 17;359(3):285-92 - PubMed
  34. J Cell Mol Med. 2006 Jan-Mar;10(1):157-65 - PubMed

Publication Types